Allarity Therapeutics, Inc. Share-based Payment Arrangement, Expense, Tax Benefit
Allarity Therapeutics, Inc. (ALLR) reported Share-based Payment Arrangement, Expense, Tax Benefit of $59.00 thousand for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-10-07.
Discontinued › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2022-10-07
- Allarity Therapeutics, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2022-06-30 was $59.00K.
- Allarity Therapeutics, Inc. share-based payment arrangement, expense, tax benefit for the quarter ending 2022-03-31 was $1.06M.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month |
|---|---|---|---|
| 2022-06-30 | $59.00K 10-Q · filed 2022-10-07 | $1.12M derived: sum of 2 quarters · filed 2022-10-07 | |
| 2022-03-31 | $1.06M 10-Q · filed 2022-05-27 | ||
| 2021-12-31 | $195.00K 10-Q · filed 2022-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |